Vanderbuilt University
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Robbins, Ivan M
IMPAHCT-FUL, NCT05557942 / 2021-006864-25: Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension

Terminated
3
186
Europe, Canada, US, RoW
AV-101
Aerovate Therapeutics, Aerovate Therapeutics Inc
Pulmonary Arterial Hypertension
08/24
08/24
IMPAHCT, NCT05036135 / 2021-001910-13: A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

Terminated
2/3
202
Europe, Canada, US, RoW
AV-101, Placebo
Aerovate Therapeutics, Aerovate Therapeutics, Inc.
Pulmonary Arterial Hypertension
08/24
08/24
ELEVATE 2, NCT04712669 / 2020-004971-42: A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension

Completed
2
108
Europe, Canada, US, RoW
rodatristat ethyl 300 mg tablet BID, rodatristat ethyl 600 mg BID, Placebo
Altavant Sciences GmbH
Pulmonary Arterial Hypertension
06/23
08/23
NCT04908397: Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension

Completed
1
10
US
L-carnitine, Carnitine, Carnitor
Vanderbilt University Medical Center
Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension, Primary Pulmonary Hypertension, Lung Diseases, Carnitine Nutritional Deficiency
06/23
06/23
NCT04469842: Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

Enrolling by invitation
1
48
US
Tacrolimus Extended Release Oral Tablet [Envarsus], Envarsus XR, Tacrolimus, Intermediate Release Tacrolimus, Prograf, FK506, Mycophenolate Mofetil Hydrochloride, MMF, CellCept, Prednisone, Deltasone, Azathioprine, Imuran
Vanderbilt University Medical Center, Veloxis Pharmaceuticals
Lung Transplant; Complications
06/26
12/26
Hedera, Peter
No trials found

Download Options